Molecular targeting of Glioblastoma – how do you hit a moving target?

per Cloughesy, Timothy F., Mischel, Paul S.
Publicat 2011

Targeted Molecular Therapy of GBM

per Mischel, Paul S., Cloughesy, Timothy F.
Publicat a Brain Pathol (2006)

Biomarkers in NOA-04: another piece to the puzzle

per Lassman, Andrew B., Cloughesy, Timothy F.
Publicat a Neuro Oncol (2016)

NovoTTF: where to go from here?

per Cloughesy, Timothy F., Lassman, Andrew B.
Publicat a Neuro Oncol (2017)

Platform trials arrive on time for glioblastoma

per Alexander, Brian M, Cloughesy, Timothy F
Publicat a Neuro Oncol (2018)

Early results from the CODEL trial for anaplastic oligodendrogliomas: is temozolomide futile?

per Lassman, Andrew B, Cloughesy, Timothy F
Publicat a Neuro Oncol (2021)

Striking the balance between PTEN and PDK1: it all depends on the cell context

per Iwanami, Akio, Cloughesy, Timothy F., Mischel, Paul S.
Publicat 2009

mTOR signaling in glioblastoma: lessons learned from bench to bedside

per Akhavan, David, Cloughesy, Timothy F., Mischel, Paul S.
Publicat 2010

SP-02 PATTERNS OF END-OF-LIFE CARE FOR PATIENTS WITH GLIOBLASTOMA

per Nghiemphu, P. Leia, Lai, Albert, Cloughesy, Timothy
Publicat a Neuro Oncol (2014)

ACTR-83. BEVACIZUMAB FOR RADIATION-INDUCED PSEUDOPROGRESSION IN ADULT SUPRASELLAR PILOCYTIC ASTROCYTOMA

per Green, Richard, Woyshner, Emily, Cloughesy, Timothy F
Publicat a Neuro Oncol (2017)

Induction of Cytomegalovirus-specific Anti-tumor Immunity after Autologous Tumor Lysate-pulsed Dendritic Cell Vaccination in a Patient with Glioblastoma

per Prins, Robert M., Cloughesy, Timothy F., Liau, Linda M.
Publicat 2008

Standards of care for treatment of recurrent glioblastoma—are we there yet?

per Weller, Michael, Cloughesy, Timothy, Perry, James R., Wick, Wolfgang
Publicat 2013

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials

per Ellingson, Benjamin M., Wen, Patrick Y., Cloughesy, Timothy F.
Publicat a Neurotherapeutics (2017)

Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma

per Ellingson, Benjamin M, Wen, Patrick Y, Cloughesy, Timothy F
Publicat a Neuro Oncol (2018)

AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas

per Guo, Deliang, Cloughesy, Timothy F., Radu, Caius G., Mischell, Paul S.
Publicat 2010

Targeted therapy for malignant glioma patients: Lessons learned and the road ahead

per Huang, Tiffany T., Sarkaria, Shawn M., Cloughesy, Timothy F., Mischel, Paul S.
Publicat 2009

Arsenic reverses glioblastoma resistance to mTOR-targeted therapies

per Iwanami, Akio, Cloughesy, Timothy F., Cavenee, Webster K., Mischel, Paul S.
Publicat 2013

Will Kinase Inhibitors Make it as Glioblastoma Drugs?

per Mellinghoff, Ingo K., Schultz, Nikolaus, Mischel, Paul S., Cloughesy, Timothy F.
Publicat 2012

NI-22 NON-ENHANCING TUMOR RESPONSE USING QUANTITATIVE T2 MAPS PREDICTS SURVIVAL IN GLIOBLASTOMA TREATED WITH BEVACIZUMAB

per Ellingson, Benjamin, Pope, Whitney, Nghiemphu, Phioanh, Lai, Albert, Cloughesy, Timothy
Publicat 2014

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

per Furnari, Frank B., Cloughesy, Timothy F., Cavenee, Webster K., Mischel, Paul S.
Publicat a Nat Rev Cancer (2015)